NSG Ventures

NSG Ventures is a Singapore-based venture capital firm and venture studio dedicated to the creation and growth of transformative life science and biotechnology companies. Established in 2020 by a team of experienced scientist-founders, including Daphne Teo and Timothy Lu, the firm employs a hands-on, founder-led investment strategy to advance medical breakthroughs. NSG Ventures provides its portfolio companies with strategic mentorship, scientific due diligence, and access to specialized lab infrastructure through its partnership with NSG BioLabs, Singapore's largest biotech co-working space. The firm's focus areas include synthetic biology, precision immuno-oncology, medical AI, and advanced biomanufacturing. With a portfolio of over 20 companies, including Engine Biosciences and Lunit, NSG Ventures aims to accelerate the translation of scientific discoveries into impactful clinical therapies. The firm operates globally, bridging the gap between academic research and commercial success in the healthcare sector.